ERBB2 and breast carcinoma: Finally, this study revealed that ZSC extract has a promising effect against HER2-positive breast cancer, therefore further pre-clinical investigations are necessary in order to evaluate its potential as a new therapeutic agent against HER2-positive breast cancer.